Insider · CIK 0001511051
Reed Vaughn Tuckson
Files at HSIC (HENRY SCHEIN INC), ADVM (Adverum Biotechnologies, Inc.). First filing -, latest -.
In brief
Reed Vaughn Tuckson files SEC Form 4 as director at HSIC (HENRY SCHEIN INC), and also at ADVM (Adverum Biotechnologies, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Reed Vaughn Tuckson has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 10 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 6, 2026 | HSIC HENRY SCHEIN INC | AGrant or award Common Stock, par value $0.01 per share | +2,577 | $0.00 | $0 | 12,520 | Mar 9, 2026 |
| Dec 9, 2025 | ADVM Adverum Biotechnologies, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -4,500 | - | - | 0 | Dec 10, 2025 |
| Dec 9, 2025 | ADVM Adverum Biotechnologies, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -4,000 | - | - | 0 | Dec 10, 2025 |
| Dec 9, 2025 | ADVM Adverum Biotechnologies, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -4,000 | - | - | 0 | Dec 10, 2025 |
| Dec 9, 2025 | ADVM Adverum Biotechnologies, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -10,520 | - | - | 0 | Dec 10, 2025 |
| Dec 9, 2025 | ADVM Adverum Biotechnologies, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -10,450 | - | - | 0 | Dec 10, 2025 |
| Jun 17, 2025 | ADVM Adverum Biotechnologies, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +10,450 | $0.00 | $0 | 10,450 | Jun 20, 2025 |
| Jun 11, 2025 | HSIC HENRY SCHEIN INC | FTax withholding Common Stock, par value $0.01 per share | -487 | $71.14 | $35k | 9,943 | Jun 12, 2025 |
| Mar 4, 2025 | HSIC HENRY SCHEIN INC | FTax withholding Common Stock, par value $0.01 per share | -572 | $70.31 | $40k | 7,586 | Mar 6, 2025 |
| Mar 4, 2025 | HSIC HENRY SCHEIN INC | AGrant or award Common Stock, par value $0.01 per share | +2,844 | $0.00 | $0 | 10,430 | Mar 6, 2025 |
Questions about Reed Vaughn Tuckson
Answered from the filings on this page, as of the latest one.
Is Reed Vaughn Tuckson buying or selling?
Reed Vaughn Tuckson has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Reed Vaughn Tuckson's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Reed Vaughn Tuckson has 0.
Where does Reed Vaughn Tuckson file Form 4?
Reed Vaughn Tuckson has filed Form 4 at HSIC (HENRY SCHEIN INC); ADVM (Adverum Biotechnologies, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.